| Literature DB >> 365072 |
J van Rossum, A R Wintzen, L J Endtz, J H Schoen, H de Jonge.
Abstract
In a double-blind controlled clinical trial on 51 patients with subarachnoid hemorrhage, tranexamic acid, 4 gm per day for ten consecutive days, did not favorably affect the outcome. Neither mortality nor rebleeding rates were improved after a follow-up of three months.Entities:
Mesh：
Substances：
Year: 1977 PMID： 365072 DOI： 10.1002/ana.410020310
Source DB: PubMed Journal: Ann Neurol ISSN： 0364-5134 Impact factor: 10.422